Matthew Pauls
2021 - Mast Therapeutics
In 2021, Matthew Pauls earned a total compensation of $1.6M as Chief Executive Officer at Mast Therapeutics, a 15% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $329,000 |
|---|---|
| Option Awards | $285,545 |
| Salary | $560,000 |
| Stock Awards | $444,000 |
| Other | $21,813 |
| Total | $1,640,358 |
Pauls received $560K in salary, accounting for 34% of the total pay in 2021.
Pauls also received $329K in non-equity incentive plan, $285.5K in option awards, $444K in stock awards and $21.8K in other compensation.
Rankings
In 2021, Matthew Pauls' compensation ranked 6,862nd out of 12,406 executives tracked by ExecPay. In other words, Pauls earned more than 44.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,862 out of 12,406 | 45th |
Division Manufacturing | 2,989 out of 5,492 | 46th |
Major group Chemicals And Allied Products | 1,325 out of 2,368 | 44th |
Industry group Drugs | 1,181 out of 2,089 | 44th |
Industry Pharmaceutical Preparations | 859 out of 1,536 | 44th |
Pay ratio
| Matthew Pauls' Pay | $1,640,358 |
|---|---|
| Median Employee's Pay | $347,829 |
| Pay Ratio | 5to 1 |
In 2021, the annual total compensation of Matthew Pauls was $1,640,358.
The annual total compensation of the median employee at Mast Therapeutics was $347,829.
The ratio of Matthew Pauls' pay to the pay of median employee was therefore 5 to one.
Source: SEC filing on April 19, 2022.
Pauls' colleagues
We found two more compensation records of executives who worked with Matthew Pauls at Mast Therapeutics in 2021.